Genetics of human plasma lipidome: Understanding lipid metabolism and its link to diseases beyond traditional lipids
Authors:
- Rubina TabassumRTRubina Tabassum
- Joel T. RämöJRJoel T. Rämö
- Pietari RipattiPRPietari Ripatti
- Jukka T. KoskelaJKJukka T. Koskela
- Mitja KurkiMKMitja Kurki
- Juha KarjalainenJKJuha Karjalainen
- Shabbeer HassanSHShabbeer Hassan
- Javier Nunez-FontarnauJNJavier Nunez-Fontarnau
- Tuomo T.J. KiiskinenTKTuomo T.J. Kiiskinen
- Sanni SöderlundSSSanni Söderlund
- Niina MatikainenNMNiina Matikainen
- Mathias J. GerlMGMathias J. Gerl
Preprint
Abstract
Aim: Genetic investigation of human plasma lipidome to get insights into lipid-related disorders beyond traditional lipid measures. Methods and Results: We performed a genome-wide association study (GWAS) of 141 lipid species (n=2,181 individuals), followed by phenome-wide scans (PheWAS) with 44 clinical endpoints related to cardiometabolic, psychiatric and gastrointestinal disorders (n=456,941 individuals). SNP-based heritability for lipid species ranged from 0.10-0.54. Lipids with long-chain polyunsaturated fatty acids showed higher heritability and genetic sharing, suggesting considerable genetic regulation at acyl chains levels. We identified 35 genomic regions associated with at least one lipid species (P−8 ), revealing 37 new SNP-lipid species pair associations e.g. new association between ABCG5/8 and CE(20:2;0). PheWAS of lipid-species-associated loci suggested new associations of BLK with obesity, FADS2 with thrombophlebitis, and BLK and SPTLC3 with gallbladder disease (false discovery rate SYNGR1, MIR100HG , and PTPRN2 in desaturation and/or elongation of fatty acids. At known lipid loci ( FADS2, APOA5 and LPL ), genetic associations provided detailed insights to their roles in lipid biology and diseases. We also show that traditional lipid measures may fail to capture lipids such as lysophospatidylcholines (LPCs) and phosphatidylcholines (PCs) that are potential disease risk factors, but are not included in routine screens. The full genome-wide association statistics are available on the web-based database ( http://35.205.141.92 ). Conclusion: Our study reveals genetic regulation of plasma lipidome and highlights the potential of lipidomic profiling in disease gene mapping.Keywords
This publication has 54 references indexed in Scilit:
- Ceramide stearic to palmitic acid ratio predicts incident diabetesDiabetologia, 2018
- Plasma lipidome patterns associated with cardiovascular risk in the PREDIMED trial: A case-cohort studyInternational Journal of Cardiology, 2018
- Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus PanelEuropean Heart Journal, 2017
- Circulating Ceramides Predict Cardiovascular Outcomes in the Population-Based FINRISK 2002 CohortArteriosclerosis, Thrombosis, and Vascular Biology, 2016
- Plasma Lipidomic Profiles Improve on Traditional Risk Factors for the Prediction of Cardiovascular Events in Type 2 Diabetes MellitusCirculation, 2016
- Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterolEuropean Heart Journal, 2016
- Lipidomics Profiling and Risk of Cardiovascular Disease in the Prospective Population-Based Bruneck StudyCirculation, 2014
- Plasma Phospholipid Fatty Acid Concentration and Incident Coronary Heart Disease in Men and Women: The EPIC-Norfolk Prospective StudyPLOS Medicine, 2012
- The Human Plasma LipidomeNew England Journal of Medicine, 2011
- Use of Multiple Metabolic and Genetic Markers to Improve the Prediction of Type 2 Diabetes: the EPIC-Potsdam StudyDiabetes Care, 2009